Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Patients with total IgG <400 mg/dL while receiving rituximab should
Patients with total IgG <400 mg/dL while receiving rituximab should
by ivy
NOT. receive IgG replacement therapy. . AAIFNC F...
Carfilzomib , Rituximab and Dexamethasone (
Carfilzomib , Rituximab and Dexamethasone (
by mindeeli
CaRD. ) Is Highly . Active and . Offers a Neuropat...
rials as treatment options for eligible patients
rials as treatment options for eligible patients
by elysha
Page 1 of 13 Note : Consider C linical T . Wa...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by alexa-scheidler
Contemporary Treatment Strategies and Optimal Seq...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by tatiana-dople
Contemporary Treatment Strategies and Optimal Seq...
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
by ellena-manuel
Swiss Group for Clinical Cancer Research (SAKK). ...
Indolent Non-Hodgkin L
Indolent Non-Hodgkin L
by danika-pritchard
ymphoma. Sobia Ozair. March 8, 2017. MD Anderson ...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Published in nejm in sep 2016
Published in nejm in sep 2016
by Wildboyz
RITUXIMAB IN B-LINEAGE ADULT ACUTE LYMPHOBLASTIC L...
227 EMEA 2005 Since all the treatment regimens used so far have only
227 EMEA 2005 Since all the treatment regimens used so far have only
by priscilla
Zevalin, supplied as kit for radiopharmaceutical p...
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
by celsa-spraggs
Emerging Treatments . Description of Program. Thi...
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
by luanne-stotts
Moderator. Neil Love, MD. Mollie Moran, MSN, CNP,...
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
AuthorsAcceptedManuscriptCryoglobulinemicvasculitisandskinulcersOurth
AuthorsAcceptedManuscriptCryoglobulinemicvasculitisandskinulcersOurth
by danya
www.elsevier.com/locate/semarthrit Our therapeutic...
Mantelcell
Mantelcell
by tawny-fly
. lymfom. Från. indolent till aggressive . sju...
Overall Survival Benefit of
Overall Survival Benefit of
by tatyana-admore
Obinutuzumab. Over Rituximab when Combined with ...
Mature Results from ECOG Study E1405 — A Phase II Study of
Mature Results from ECOG Study E1405 — A Phase II Study of
by webraph
VcR. -CVAD with Maintenance Rituximab for Previous...
Cheson B et al. Proc ASH
Cheson B et al. Proc ASH
by pattyhope
2016;Abstract 615; Sehn LH. et al. . Lancet . Onc...
Antibody-based Therapies
Antibody-based Therapies
by osullivan
Dr. John Kuruvilla. Princess Margaret Cancer Centr...
Thyroid eye disease B.Eshraghi
Thyroid eye disease B.Eshraghi
by brown
M.D. Associate professor of ophthalmology. Ophthal...
In the name of god brief review on
In the name of god brief review on
by SugarAndSpice
nhl. Presenting by . F.Malek. M.D. Assistant Prof...
Practice Guidelines
Practice Guidelines
by roy
Clinical Haematology, University Hospital Liège a...
266 Cancer Control
266 Cancer Control
by iris
Gum Drop Mushrooms . Photograph courtesy of Sherri...
Understanding Lymphoma Series
Understanding Lymphoma Series
by evans
Helpline: 800 500 9976 | helpline@lymphoma.org U...
Understanding Lymphoma Series
Understanding Lymphoma Series
by jones
Helpline: 800 500 9976 | helpline@lymphoma.org U...
CASE REPORT
CASE REPORT
by willow
33 37 EN Recurrent Mixed Cryoglobulinemia (MCS): ...
BC Cancer Protocol Summary LYCHOPRMTXPage of
BC Cancer Protocol Summary LYCHOPRMTXPage of
by melody
Activated: 1 Jun 2014 Revised: Mar 2022tests rev...
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
by isabella2
Dr. Gilles SALLES. Chief . of. . the. . Lymphoma...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
HIV and Non Hodgkin Lymphoma
HIV and Non Hodgkin Lymphoma
by karlyn-bohler
Virginia C. . Broudy. , MD. September 25, 2014. P...